Table 6.

Experimental affinities of FVIII2194-2205 peptides for 10 HLA-DR proteins

Reference peptide*FVIII2194-2205F2196AF2196KM2199AM2199R
DRB1*01:01 0.3 ± 0.0 0.3 ± 0.0 >50 >50 39.8 ± 3.2 >50 
DRB1*03:01 3.9 ± 0.7 >50 >50 >50 28.5 ± 2.9 >50 
DRB1*04:01 1.1 ± 0.2 36.3 ± 4.8 >50 >50 >50 >50 
DRB1*04:04 0.02 ± 0.00 39.1 ± 5.0 >50 >50 >50 >50 
DRB1*07:01 0.3 ± 0.1 >50 >50 >50 >50 >50 
DRB1*09:01 0.1 ± 0.0 42.0 ± 5.2 >50 >50 3.5 ± 0.3 >50 
DRB1*10:01 2.9 ± 0.4 7.3 ± 0.7 >50 >50 >50 >50 
DRB1*11:01 4.4 ± 0.7 >50 >50 >50 >50 >50 
DRB1*11:04 3.8 ± 0.5 >50 >50 >50 >50 >50 
DRB1*15:01 0.06 ± 0.01 5.8 ± 0.5 >50 >50 >50 >50 
Reference peptide*FVIII2194-2205F2196AF2196KM2199AM2199R
DRB1*01:01 0.3 ± 0.0 0.3 ± 0.0 >50 >50 39.8 ± 3.2 >50 
DRB1*03:01 3.9 ± 0.7 >50 >50 >50 28.5 ± 2.9 >50 
DRB1*04:01 1.1 ± 0.2 36.3 ± 4.8 >50 >50 >50 >50 
DRB1*04:04 0.02 ± 0.00 39.1 ± 5.0 >50 >50 >50 >50 
DRB1*07:01 0.3 ± 0.1 >50 >50 >50 >50 >50 
DRB1*09:01 0.1 ± 0.0 42.0 ± 5.2 >50 >50 3.5 ± 0.3 >50 
DRB1*10:01 2.9 ± 0.4 7.3 ± 0.7 >50 >50 >50 >50 
DRB1*11:01 4.4 ± 0.7 >50 >50 >50 >50 >50 
DRB1*11:04 3.8 ± 0.5 >50 >50 >50 >50 >50 
DRB1*15:01 0.06 ± 0.01 5.8 ± 0.5 >50 >50 >50 >50 

Affinities were determined using a competitive binding assay. HLA-DR proteins were incubated with 0.05, 0.1, 0.5, 1, 5, 10, and 50 μM FVIII peptides plus the relevant biotinylated reference peptides as competitors for each HLA-DR (supplemental Table 1) and immobilized in wells coated with the anti-DR antibody L243. After washing, the remaining bound biotinylated peptide was labeled using europium-conjugated streptavidin and quantified using a time-resolved fluorometer.

*

Numbers are IC50 values (concentration in μM displacing 50% of the reference peptide) ± standard error (SE). IC50 values were calculated from sigmoidal binding curves using SigmaPlot. Reference peptide affinities were similar to those reported previously.32,71 

or Create an Account

Close Modal
Close Modal